影响2002年中国经济增长的因素分析

影响2002年中国经济增长的有利因素有：以扩大和培育内需为主导的宏观经济政策，民间投资需求出现恢复性增长，工业结构调整与发展并进。但也存在值得注意的问题：居民消费需求增长存在制约，农民收入水平亟待提高，出口形势不容乐观。     

金融危机救助方案与成本分担机制分析

各国政府应对本轮金融危机的救助虽取得一定成效,但仍然引发了关于救助方案的选择和救助成本等相关问题的探讨。英美等发达国家的救助基本遵循了依靠市场或私人机构进行救助,政府尽量不采取直接的干预,以减少政府救助成本。资产负债表重构这一救助方式能将救助成本分担到私人机构,在合适的条件下应用,可以降低救助道德风险发生的可能性,并且极大地减少政府的救助成本。     

Effects of cross-border capital flows on stock returns of dual-listed firms in mainland China and Hong Kong: Evidence from a natural experiment

This study analyses the effects of the Shanghai–Hong Kong Stock Market Connect policy on the price disparity between A-shares and H-shares of dual-listed companies (DLC). Using a difference-in-difference estimation method, we show that the policy decreases the relative twin cumulative abnormal returns of treated DLC by 3% and narrows the price gaps between A-shares and H-shares. We determine that the rising demand for H-shares, which are newly accessible by mainland investors, drives the price of H-shares up. By contrast, the price of A-shares remains unchanged. Further analysis reveals that cross-border capital flow is the main force of the policy.     

近代中国中央银行制度思想演进

从清末(1884～1911年)、北洋政府(1911～1927年)到国民政府时期(1927～1949年),社会各界对于中国建立中央银行制度的必要性、中央银行的产权结构与组织形式、中央银行的独立性、中央银行的职能作用等问题,进行了长期不懈的理论探讨,提出了许多设想和建议,推动了中央银行制度在近代中国的建立与发展.     

试论WTO体制下的贸易保护主义及应对策略

贸易保护主义的愈演愈烈，已对WTO的自由贸易体制造成了冲击。对WTO体制下贸易保护主义的表现及特性进行分析，并提出应对策略，是学术界的重要任务。     

Bundling strategy and product differentiation

The existing literature shows that a decrease in the degree of substitutability increases a monopoly’s incentive to bundle. This paper in addition takes into account competition in the second product market and then re-examines how intra-brand and inter-brand product differentiations affect the incentive to bundle. In order to formally examine the above conjectures, this research builds up a two-firm, two-product model in which product 1 (monopoly product) is produced only by the bundling firm and product 2 (competing product) is produced by both firms. The analysis shows that under both Bertrand and Cournot competitions the incentive to bundle does not necessarily increase with the degree of intra-brand differentiation, while it strictly decreases with the degree of inter-brand differentiation. Moreover, under Bertrand competition bundling always decreases consumer surplus, but may increase the competitor’s profit and social surplus. Under Cournot competition bundling always reduces the opponent’s profit and social welfare, but may increase consumer surplus.     

客运企业服务品质综合评价模型研究——基于顾客满意度理论

本文将顾客满意度理论应用于交通运输行业,建立了用于衡量旅客运输企业服务品质的旅客满意度评价理论框架,框架由6个因素组成,其中预期质量、感知质量和感知价值是旅客满意度的原因变量,旅客抱怨和旅客忠诚则是旅客满意度的结果变量。基于上述6变量本文分别设计了评价指标体系,并设计了评价流程。     

我国老年人日常生活自理健康预期寿命的差异性分析

健康是人们关心的热点问题,对老年人来说,不仅要长寿,而且要健康,要尽可能长久地保持生活自理能力,提高自身的生命质量。回答我国老年人的日常生活不能自理期是压缩还是扩展了,分析影响老年人日常生活自理能力的因素。采用1992年和2002年两次全国老年调查数据,做分城乡、分性别、分年龄的不同老年人生活自理健康预期寿命的差异性分析。在1992年和2002年期间,城镇老年人和农村老年人日常生活不能自理期均在“扩展”;2002年卧床不起的疾病对老年人日常活动影响更大,老年人2002年比1992年在生活自理方面需要更多的照料资源。     

Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among venous thromboembolism patients

Objective:

This study evaluated differences in medical costs associated with clinical end-points from randomized clinical trials that compared the new oral anticoagulants (NOACs), dabigatran, rivaroxaban, apixaban, and edoxaban, to standard therapy for treatment of patients with venous thromboembolism (VTE).

Research design and methods:

Event rates of efficacy and safety end-points from the clinical trials (RE-COVER, RE-COVER II, EINSTEIN-Pooled, AMPLIFY, Hokusai-VTE trial) were obtained from published literature. Incremental annual medical costs among patients with clinical events from a US payer perspective were obtained from the literature or healthcare claims databases and inflation adjusted to 2013 costs. Differences in total medical costs associated with clinical end-points for the NOACs vs standard therapy were then estimated. One-way and Monte Carlo sensitivity analyses were carried out.

Results:

A lower rate of major bleedings was associated with use of any of the NOACs vs standard therapy. Except for dabigatran, use of NOACs was also associated with a lower rate of recurrent VTE/death. As a result of the reduction in clinical event rates, the overall medical cost differences were ?$146, ?$482, ?$918, and ?$344 for VTE patients treated with dabigatran, rivaroxaban, apixaban, and edoxaban, respectively, vs patients treated with standard therapy.

Conclusions:

When any of the four NOACs are used instead of standard therapy for acute VTE, treatment medical costs are reduced. Apixaban is associated with the greatest reduction in medical costs, which is driven by medical cost reductions associated with both efficacy and safety end-points. Further evaluation may be needed to validate these results in the real-world setting.     

海峡两岸经济合作:创新与双赢——第二次海峡两岸经济发展论坛综述

2008年5月17～18日,由国际欧亚科学院中国科学中心发起,福建师范大学、厦门大学、福建省社会科学界联合会联合主办的第二次“海峡两岸经济发展论坛（福州）”在福州举行。来自大陆、台湾、香港的知名专家学者、企业界高层人士、120余人参加会议。专家们从两岸经济合作发展的新机遇、制度创新与创造双赢、两岸经济进一步合作的动力、基础与模式、两岸产业合作、建设海峡西岸经济区等方面,阐述了各自的思考、建议与依据。现将论坛的主要观点综述如下。